On December 13, 2025, Jade Biosciences, Inc. entered into a securities purchase agreement for a private placement of 3,214,286 shares at $14.00 each, aiming to raise approximately $45 million for R&D and operating expenses. The transaction is expected to close on December 16, 2025.